Brecht Laforce

Brecht Laforce

Auto-generated profile, based on publicly available information

Brecht Laforce

Department of Chemistry, Ghent University, Ghent, Belgium

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
BLBrecht Laforce
Brecht Laforce
BMBert Masschaele
Bert Masschaele
Matthieu BooneMatthieu Boone
Matthieu Boone
David SchaubroeckDavid Schaubroeck
David Schaubroeck
MDManuel Dierick
Manuel Dierick
LVLaszlo Vincze
Laszlo Vincze

16 March 2017 in Analytical Chemistry
Verified
Journal Article
Closed access
SMStijn J. M. Van Malderen
Stijn J. M. Van Malderen
BLBrecht Laforce
Brecht Laforce
TAThibaut Van Acker
Thibaut Van Acker
CNCharlotte Nys
Charlotte Nys
MRMaarten De Rijcke
Maarten De Rijcke
FVFrank Vanhaecke
Frank Vanhaecke

1 November 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
CCCharlotte Carlier
Charlotte Carlier
BLBrecht Laforce
Brecht Laforce
SMStijn J. M. Van Malderen
Stijn J. M. Van Malderen
FGFélix Gremonprez
Félix Gremonprez
RTRemi Tucoulou
Remi Tucoulou
Wim CeelenWim Ceelen
Wim Ceelen

21 July 2016 in Scientific Reports
Verified
Journal Article
Open access
BLBrecht Laforce
Brecht Laforce
CCCharlotte Carlier
Charlotte Carlier
BVBart Vekemans
Bart Vekemans
JVJulie Villanova
Julie Villanova
RTRémi Tucoulou
Rémi Tucoulou
LVLaszlo Vincze
Laszlo Vincze
Ovarian cancer is amongst the most common types of cancer in women, with a relatively low overall cure rate of approximately 30%. This is therefore an important incentive to urge for further research in order to maximize the chances of survival for these patients. Intraperitoneal chemotherapy with Cisplatin is an effective treatement for ovarian cancer; however, many questions still remain concerning the ideal treatment protocol and tumor resistance towards the drug, which should be resolved for optimal application of this therapy. For the first timein-vivogrown tumors treated with both hyper- and normothermic intraperitoneal chemotherapy have been studied using nano-XRF spectroscopy to examine the platinum (Pt) distribution within the analyzed tissues. These measurements prove Pt resides predominantly outsides the cancer cells in the stroma of the tissue. These findings indicate the resistance mechanism of the cancer cells prevents Cisplatin from diffusing through their cell membranes. This is an important addition to the existing knowledge on the resistance mechanism providing insights which might help to overcome this effect. In our aim to find the optimal treatment protocol, no significant differences were found between the two examined procedures. A more extensive data set will be needed to draw definite conclusions.

2 August 2019 in Environmental Science & Technology
Verified
Journal Article
Closed access
CPCarlo Porfido
Carlo Porfido
IAIgnazio Allegretta
Ignazio Allegretta
OPOnofrio Panzarino
Onofrio Panzarino
BLBrecht Laforce
Brecht Laforce
BVBart Vekemans
Bart Vekemans
Matteo SpagnuoloMatteo Spagnuolo
Matteo Spagnuolo

1 May 2020 in Radiation Physics and Chemistry
Verified
Journal Article
Closed access
BGBo Gao
Bo Gao
BLBrecht Laforce
Brecht Laforce
JDJelle Dhaene
Jelle Dhaene
LVLaszlo Vincze
Laszlo Vincze
LHLuc Van Hoorebeke
Luc Van Hoorebeke
Matthieu BooneMatthieu Boone
Matthieu Boone